Basic Vigora Information

• INN (International Nonproprietary Name): Sildenafil
• Brand Names Available In United Kingdom: Viagra, Generic Sildenafil
• ATC Code: G04BE03
• Forms & Dosages: Tablets (25mg, 50mg, 100mg); Oral Suspension (10mg/mL for PAH as Revatio); Chewable Tablets (50mg, 100mg in some generics)
• Manufacturers In United Kingdom: not specified
• Registration Status In United Kingdom: not specified
• OTC / Rx Classification: Prescription (Rx) only

Key Findings From Recent Trials

Major 2022–2025 Studies

Patients and prescribers have seen multiple randomised controlled trials and pooled analyses published since 2022 assessing sildenafil for erectile dysfunction.

These trials include phase III placebo‑controlled studies and meta‑analyses comparing sildenafil with other phosphodiesterase type 5 inhibitors.

Study cohorts covered a range of baseline ED severity and included older men and those with comorbidities typical of UK primary care practice.

Main Outcomes

Across high‑quality trials, sildenafil produced clinically meaningful improvements on the International Index of Erectile Function (IIEF) versus placebo.

Response rates in trial cohorts commonly ranged between approximately 60% and 80%, depending on baseline severity.

Comparative effectiveness work confirms sildenafil’s rapid onset, usually 30–60 minutes, compared with longer‑acting agents such as tadalafil.

Improvements in erection hardness and successful intercourse attempts were consistently reported in sildenafil arms.

Safety Observations

Safety data from trial safety arms and post‑marketing pharmacovigilance remain consistent with the established profile for sildenafil.

Common, dose‑related adverse events include headache, flushing, dyspepsia and transient visual disturbances.

Serious events such as priapism and sudden hearing loss are rare but remain recognised risks that require urgent attention.

Recent reports emphasise drug–drug interactions as an important safety trend, notably with potent CYP3A4 inhibitors and with nitrates, which are the principal cause of serious hypotension events.

Clinical Mechanism Of Action

Layman’s Explanation

Sildenafil helps the biological process of getting and maintaining an erection by increasing blood flow into the penis during sexual stimulation.

It does not create sexual desire and only works when the patient is sexually aroused.

Scientific Breakdown

Pharmacodynamics

Sildenafil is a selective phosphodiesterase type 5 (PDE5) inhibitor acting primarily in the corpus cavernosum.

By blocking PDE5, sildenafil reduces cGMP degradation and thereby amplifies nitric‑oxide‑mediated smooth muscle relaxation.

The resulting vasodilation increases penile blood inflow and supports erection under sexual stimulation.

Pharmacokinetics

Film‑coated tablet formulations of sildenafil are available in 25mg, 50mg and 100mg strengths and are absorbed with Tmax around 30–120 minutes depending on food intake.

Hepatic metabolism via CYP3A4 is the predominant route of clearance, so interactions and dose adjustments are guided by concomitant medicines and liver or kidney impairment.

Clinical Implications

Onset is typically 30–60 minutes with a usual duration of effect of about 4–6 hours for erectile activity.

Because of the metabolic pathway and duration, daily dosing is not recommended unless a clinician prescribes an alternative regimen.

Revatio formulations used for pulmonary arterial hypertension have different dosing and should not be used interchangeably with ED regimens.

Scope Of Approved & Off-Label Use

United Kingdom Approvals

Sildenafil as an active substance is authorised in Europe and many markets for erectile dysfunction under brand names such as Viagra and as generic sildenafil tablets.

Revatio is the licensed preparation for pulmonary arterial hypertension and uses a different dosing schedule (20mg three times daily) and formulation (including an oral suspension).

Vigora is a prominent Indian brand manufactured by Zydus Cadila and widely exported, but its authorisation status in the UK should be verified by purchasers and pharmacists.

Notable Off‑Label Trends

Clinicians sometimes consider sildenafil off‑label for specific vascular problems or sexual dysfunction subtypes, but evidence is mixed and not routine practice.

Examples in the literature include adjunct use for premature ejaculation or exploratory research into female sexual arousal, but these are not established indications.

Online procurement of Indian generics such as Vigora is common globally; patients should confirm regulatory status and batch authenticity for UK supply.

Dosage Strategy

General Dosing

The typical adult starting dose for erectile dysfunction is 50mg taken as needed about 30–60 minutes before sexual activity.

Depending on efficacy and tolerability, clinicians may adjust to 25mg or 100mg and patients must not exceed one dose in 24 hours.

For pulmonary arterial hypertension, use licensed Revatio dosing rather than ED regimens.

Condition‑Specific Dosing

Erectile Dysfunction

Begin usually with 50mg for most adults and reduce to 25mg for elderly patients or those at higher risk due to interacting drugs or hepatic/renal impairment.

Titrate upward to 100mg only if 50mg is ineffective and tolerated; maintain one dose per 24 hours maximum.

Pulmonary Arterial Hypertension

PAH dosing is specific to Revatio: 20mg three times daily, administered under specialist supervision, and is not interchangeable with ED packs such as Vigora or Viagra.

Special Populations

Sildenafil is not indicated for ED in patients under 18 years of age.

Elderly patients require monitoring for comorbidities, and those with hepatic or renal impairment should start at the lowest effective dose, usually 25mg.

Safety Protocols

Contraindications

Concomitant use with organic nitrates is an absolute contraindication because of the risk of life‑threatening hypotension.

Do not prescribe or supply sildenafil to patients with recent myocardial infarction, unstable angina, severe hypotension, or known hypersensitivity to sildenafil.

Exercise caution in aortic stenosis, bleeding disorders, sickle cell disease and severe hepatic impairment as listed in product information.

Adverse Effects

Common, dose‑dependent adverse effects include headache, flushing, nasal congestion and dyspepsia.

Transient visual disturbances such as a blue tint or blurred vision and muscle or back pain are documented and usually resolve without intervention.

Rare but serious events include priapism and sudden hearing loss; emergency care is required for erections lasting longer than four hours or sudden sensory changes.

Pharmacists providing Viagra Connect or prescription sildenafil should counsel patients on these risks and the need for urgent assessment if severe symptoms occur.

Interaction Mapping

Food Interactions

Taking sildenafil after a heavy, high‑fat meal delays absorption and can postpone onset of action, so advise patients accordingly if rapid onset is desired.

Moderate alcohol consumption is generally tolerated, but excess alcohol increases the risk of dizziness or orthostatic symptoms and may reduce sexual performance.

Drug Combinations To Avoid

Organic nitrates used for angina and recreational alkyl nitrites (“poppers”) must not be used with sildenafil due to profound hypotension risk.

Absolute/Major Avoidances

Any nitrate therapy—oral, topical or inhaled—is a contraindication to sildenafil.

Significant Interactions

Potent CYP3A4 inhibitors such as ritonavir, ketoconazole and clarithromycin increase sildenafil exposure; start lower (25mg) and monitor for side effects.

CYP3A4 inducers like rifampicin can reduce sildenafil effectiveness and may necessitate dose review.

Cautionary Combinations

Alpha‑blockers may cause symptomatic hypotension when co‑administered; stabilise blood pressure on alpha‑blocker therapy before introducing sildenafil at the lowest dose.

Concomitant use of different PDE5 inhibitors is not advised.

Patient Experience Analysis

Survey Data

Real‑world surveys and clinic registries show high satisfaction when sildenafil is prescribed appropriately for ED.

Many men report clearer erections, improved confidence and better sexual performance after starting sildenafil tablets.

Common patient complaints centre on transient side effects such as headache and flushing, and on unmet expectations where libido was not affected.

Forum Trends

Online discussion boards and e‑pharmacy reviews frequently highlight price, brand recognition and ease of access as key drivers for purchase decisions.

Vigora is often chosen for affordability and availability in 50mg and 100mg blister packs, but users also warn about verifying product authenticity when buying from international suppliers.

Safety stories on forums commonly stress interactions with nitrates and the importance of professional advice rather than self‑medication.

Distribution & Pricing Landscape

Market Snapshot

Vigora is manufactured by Zydus Cadila in India and commonly packaged in red blister strips of 4 or 10 tablets at 50mg or 100mg strengths.

In the UK market, sildenafil is supplied as branded Viagra, as generics and under pharmacy supply routes for suitable products and patients.

Because Vigora is widely exported through Indian e‑pharmacies, it is one of the most searched generic Viagra brands worldwide.

Pricing Dynamics

Generic manufacturers such as Cipla and Sun Pharma generally undercut branded Viagra on unit price and drive the online market.

UK pharmacy routes may involve consultation fees for pharmacy supply options and prescription charges where applicable.

Supply‑chain scrutiny and verification of batch certificates are increasingly important for cross‑border purchases and wholesaler procurement.

Alternative Options

Comparison Table

Sildenafil provides a relatively rapid onset (30–60 minutes) and duration of around 4–6 hours, making it suitable for planned activity.

Tadalafil offers a longer action—up to 36 hours—and a daily low‑dose option for spontaneous activity, at the cost of a longer side‑effect window.

Vardenafil is similar to sildenafil in onset and may be an alternative for some non‑responders.

Avanafil can produce faster onset in some studies and may suit patients seeking a shorter adverse‑event window.

Pros And Cons

Choice between agents should be individualised by considering onset, duration, comorbidities, drug interactions, cost and availability.

For pulmonary arterial hypertension, select Revatio formulations and dosing rather than ED packs or regimens.

Regulatory Status

Sildenafil (INN) is classified under ATC code G04BE03 and is regulated as a prescription medicine for ED in most markets.

In India, Vigora (Zydus Cadila) is CDSCO‑approved and marketed widely for ED in 50mg and 100mg strengths.

Viagra and generic sildenafil are authorised across Europe and the US for ED; Revatio is licensed for PAH with different dosing and formulations.

Pharmacovigilance remains active; clinicians and pharmacists in the UK should report adverse events to the Yellow Card scheme.

Consolidated FAQ

Common Patient Questions & Concise Answers

Is Vigora the same as Viagra?

The active ingredient in both is sildenafil; Vigora is an Indian branded generic and, if quality assured, produces similar effects to Viagra tablets.

Can I buy sildenafil without a prescription in the UK?

Some sildenafil options are available via pharmacy supply pathways in the UK but most strengths and brands remain prescription‑only; check with a pharmacist.

What dose should I start?

Start with 50mg for erectile dysfunction unless a clinician advises 25mg for increased risk or 100mg if 50mg is ineffective and tolerated.

What are the main risks?

The major risk is combining sildenafil with nitrates, which can cause severe hypotension; common side effects include headache and flushing.

Can I take Vigora for pulmonary arterial hypertension?

PAH requires licensed Revatio formulations; Vigora marketed for ED is not indicated for PAH.

How should I store sildenafil?

Store tablets in their original packaging below 30°C and do not freeze oral suspensions.

Visual Guide

Suggested Infographics & Clinical Figures

Include a simple mechanism diagram that shows nitric oxide leading to cGMP, PDE5 inhibition and penile vasodilation, with lay and clinical labels.

Create a dosing timeline visual for 25mg, 50mg and 100mg indicating onset (30–60 minutes), peak and typical duration (4–6 hours) and the effect of heavy meals.

Design an interaction map with nitrates in red, potent CYP3A4 inhibitors in orange and moderate interactions in yellow for patient handouts.

Show clear packaging comparisons between Vigora blister packs, Viagra boxes and Revatio suspension with alt text for accessibility.

Add safety alert icons for priapism, visual changes and hypotension with specific instructions on when to seek care.

Storage & Transport

Keep sildenafil tablets in original packaging below 30°C and protected from moisture.

Do not freeze the Revatio oral suspension and observe manufacturer expiry dates and batch details.

For cross‑border supply, follow Good Distribution Practice and verify supplier licences and batch certificates when sourcing Vigora or other generics from overseas.

Advise patients to return unused or expired medicines to a pharmacy for safe disposal per NHS guidance.

Guidelines For Proper Use

Clinical Checklist & Patient Guidance

Screen patients for nitrate use, recent myocardial infarction or unstable angina, and for other cardiovascular contraindications before prescribing or supplying sildenafil.

Review concomitant medicines for CYP3A4 inhibitors or alpha‑blockers and consider starting at 25mg in higher‑risk patients.

Advise patients to take sildenafil around 30–60 minutes before sexual activity and to avoid heavy meals if a quick onset is required.

Counsel on common side effects and warn patients to seek urgent help for erections lasting longer than four hours or sudden vision or hearing loss.

Encourage sourcing from regulated pharmacies, and document counselling and follow‑up for efficacy and tolerability.

Patient Purchase Note

Our online pharmacy supplies vigora without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Delivery Across United Kingdom

Concluding Safety Reminders

Always confirm the active ingredient (sildenafil citrate) and ensure appropriate screening for nitrates and cardiovascular risk before supply.

Advise patients that sildenafil requires sexual stimulation to work and does not protect against sexually transmitted infections.

Encourage reporting of adverse events to the Yellow Card scheme and document follow‑up for efficacy and tolerability in clinic records.

When sourcing Vigora or other generics, verify supplier credentials and batch authenticity and store products according to manufacturer guidance below 30°C.